Cutaneous manifestations of internal malignancy

Published on 05/03/2015 by admin

Filed under Dermatology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 5 (1 votes)

This article have been viewed 3080 times

Chapter 35 Cutaneous manifestations of internal malignancy

3. Describe the cutaneous lesions of Sweet’s syndrome.

The clinical hallmark of Sweet’s syndrome is the presence of sharply demarcated, painful plaques on the face, neck, upper trunk, and extremities (Fig. 35-1). The surface of the plaques has a mammillated (nipple-like) appearance and often shows papulovesicles and pustules. Some lesions have a target-like appearance, and lesions on the lower extremities may resemble erythema nodosum. Oral mucous membrane and eye lesions can be seen. Skin lesions may develop at the site of minor skin trauma or needle-sticks in a small subset of patients. This phenomenon is called pathergy and is also seen in pyoderma gangrenosum and Behçet’s syndrome.

8. What is necrolytic migratory erythema?

This characteristic skin eruption is associated with an α-cell tumor of the pancreas. It presents as erythema with superficial pustules and erosions, typically involving the face, intertriginous skin, and acral extremities (Fig. 35-3). Alopecia, weight loss, glossitis, stomatitis, nail dystrophy, anemia, and diabetes are frequent associations. The eruption tends to migrate and desquamate, and most patients have elevated glucagon serum levels (glucagonoma syndrome). Skin biopsy shows necrosis of the upper portion of the epidermis and is usually diagnostic. This unique skin disease is probably related to low serum amino acid levels.

Zettouni N, Harvey N: Glucagonoma syndrome, eMedicine Online, http://www.emedicine.com. May 2008.

18. Where does Paget’s disease most commonly occur?

29. Can pyoderma gangrenosum be associated with internal malignancy?

Yes. Pyoderma gangrenosum (PG) is an ulcerative skin disease of unknown etiology. The lesions are painful, may rapidly enlarge, and are characterized by an erythematous or violaceous undermined border with a necrotic center (Fig. 35-8). The most common diseases associated with PG are inflammatory bowel disease, rheumatoid arthritis, and a small subset may have monoclonal IgA gammopathy. In a review of several studies, PG was associated with internal malignancy in 7.2% of patients. Leukemia is the most frequently reported malignancy with myelocytic and myelomonocytic leukemia accounting for the majority of cases. Other reported hematologic cancers are multiple myeloma, polycythemia vera, and lymphoma. In two thirds of the cases associated with myelocytic leukemia, the PG preceded or was concurrent with the diagnosis of the leukemia. There are rare sporadic reports of PG associated with solid tumors.

Callen J, Jackson JM: Pyoderma gangrenosum: an update, Rheumatol Dis Clin N Am 33:787–802, 2007.

34. What is carcinoid syndrome? Does it have prognostic significance?

Carcinoid syndrome is a systemic manifestation of neuroendocrine carcinoid tumors that manifest most commonly by flushing that progresses to persistent telangiectasia (Fig. 35-9) and diarrhea. Less common findings include bronchospasm, cardiac valvular dysfunction, and pellagra-like skin changes (photodistributed dermatitis). It is estimated that 10% of patients with carcinoid tumors will develop this syndrome. Development of this syndrome has prognostic significance, as liver metastases underlie most cases, and thus it signifies metastatic, unresectable disease.

Santacroce L, Diomede D, Balducci L: Malignant carcinoid syndrome, eMedicine Online, http://www.emedicine.com. November 2009.